Northwire Canada EditionSaturday, July 25, 2026
Northwire
B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9% B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9%
Management

Former Zefiro Founder and Chairman Intends to Nominate Alternative Slate of Directors

ZEFI · Price

Executive Summary

  • Dr. Talal A. Debs, founder of Zefiro Methane Corp. and largest single shareholder (≈27% stake), announced he no longer has confidence in current management and intends to nominate an alternative slate of directors for the upcoming annual general meeting (AGM) scheduled no later than Dec 31 2025.
  • The dissent includes a planned open letter to shareholders detailing alleged mismanagement, lack of strategic focus, and governance deficiencies by the incumbent board and executives.
  • Dr. Debs disclosed that any proxy solicitation costs will be borne by his firm X Machina Capital Strategies (XMC), with potential reimbursement from Zefiro, and indicated a possible dissident information circular will be filed in compliance with NI 51‑102.

Key Details

  • Shareholder Position: XMC and related entities hold 20,711,500 common shares of Zefiro, representing 27.26% of the issued and outstanding common shares (as of Sept 29 2025).
  • Intent to Nominate: Dr. Debs will nominate an alternative slate of directors for election at the AGM; no meeting date has been set yet.
  • Open Letter: An open letter to shareholders will be issued, highlighting perceived mismanagement and governance failures of current board and management.
  • Proxy Solicitation: No proxy solicitation is occurring at this time; any future solicitation costs will initially be covered by XMC, with possible reimbursement from Zefiro.
  • Regulatory Filings: The release satisfies NI 51‑102 continuous disclosure obligations and the Early Warning Report under NI 62‑103 due to a change in intent regarding board composition.
  • Potential Dissident Circular: Dr. Debs may file a dissident information circular prior to the AGM, as permitted by Canadian securities law.

Notable Quotes

(No direct quotes from executives were provided in the release.)

Read the original news release →

More from ZEFIRO METHANE CORP.